Skip to content
Business Times – Lifestyle
Author:
Rise Therapeutics
Rise Therapeutics Completes Enrollment in Four-Week Dose Expansion Cohort for the R-2487 Rheumatoid Arthritis Clinical Trial
June 2, 2026